Parainfluenza virus type 3 infections in a hematology unit View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2001-02

AUTHORS

U Hohenthal, J Nikoskelainen, R Vainionpää, R Peltonen, M Routamaa, M Itälä, P Kotilainen

ABSTRACT

Parainfluenza virus type 3 (PIV3) is associated with a high mortality rate in BMT recipients with lower respiratory tract infections. We describe nine patients with hematological malignancies (five having undergone either allogeneic or autologous stem cell trans- plantation) identified as having PIV3 infection during a 2-month period in a Hematology Unit. Four patients with infiltrates on chest radiograph received intravenous ribavirin therapy; all survived. The infection was community-acquired in two patients, while nosocomial origin of the disease was evident, or presumed, in the remaining seven. The policy implemented to control the spread of PIV3 was as follows: (1) nasopharyngeal samples for antigen detection were obtained from all patients presenting with respiratory symptoms; (2) all diagnosed (or suspected) PIV3-positive hematological patients were nursed following contact isolation precautions, preferably in the Infectious Diseases Unit; and (3) staff were given further education on hospital hygiene. Our experience shows that it may be possible to avoid mortality for PIV3 lower respiratory tract infection in immunocompromised patients by early commencement of intravenous ribavirin. It is also possible, even without closing the ward, to contain nosocomial spread of PIV3 by implementing systematic nasopharyngeal sampling for rapid diagnostics, and by strict adherence to cohorting and contact isolation precautions. Bone Marrow Transplantation (2001) 27, 295–300. More... »

PAGES

295-300

References to SciGraph publications

  • 1981-01. Persistent parainfluenza virus shedding during isolation at the South Pole in NATURE
  • 1993-09. Parainfluenza virus infection in adult bone marrow transplant recipients in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 1997-05. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections in BONE MARROW TRANSPLANTATION
  • 1988. Direct Antigen Detection in LABORATORY DIAGNOSIS OF INFECTIOUS DISEASES PRINCIPLES AND PRACTICE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/sj.bmt.1702776

    DOI

    http://dx.doi.org/10.1038/sj.bmt.1702776

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1026152219

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/11277177


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical Microbiology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antigens, Viral", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cross Infection", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Finland", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Follow-Up Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematologic Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematopoietic Stem Cell Transplantation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hospital Units", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunocompromised Host", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Parainfluenza Virus 3, Human", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Paramyxoviridae Infections", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ribavirin", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hohenthal", 
            "givenName": "U", 
            "id": "sg:person.01023540424.78", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023540424.78"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nikoskelainen", 
            "givenName": "J", 
            "id": "sg:person.0623450752.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623450752.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Virology, Turku University, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.1374.1", 
              "name": [
                "Department of Virology, Turku University, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Vainionp\u00e4\u00e4", 
            "givenName": "R", 
            "id": "sg:person.0612620377.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612620377.46"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Peltonen", 
            "givenName": "R", 
            "id": "sg:person.01342274627.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342274627.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Surgery, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Routamaa", 
            "givenName": "M", 
            "id": "sg:person.0742670020.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742670020.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "It\u00e4l\u00e4", 
            "givenName": "M", 
            "id": "sg:person.01231423755.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231423755.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland", 
              "id": "http://www.grid.ac/institutes/grid.410552.7", 
              "name": [
                "Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kotilainen", 
            "givenName": "P", 
            "id": "sg:person.01137767024.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137767024.86"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/978-1-4612-3900-0_4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016607238", 
              "https://doi.org/10.1007/978-1-4612-3900-0_4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02009383", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013894701", 
              "https://doi.org/10.1007/bf02009383"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1700752", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017083491", 
              "https://doi.org/10.1038/sj.bmt.1700752"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/289187a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038585061", 
              "https://doi.org/10.1038/289187a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2001-02", 
        "datePublishedReg": "2001-02-01", 
        "description": "Parainfluenza virus type 3 (PIV3) is associated with a high mortality rate in BMT recipients with lower respiratory tract infections. We describe nine patients with hematological malignancies (five having undergone either allogeneic or autologous stem cell trans- plantation) identified as having PIV3 infection during a 2-month period in a Hematology Unit. Four patients with infiltrates on chest radiograph received intravenous ribavirin therapy; all survived. The infection was community-acquired in two patients, while nosocomial origin of the disease was evident, or presumed, in the remaining seven. The policy implemented to control the spread of PIV3 was as follows: (1) nasopharyngeal samples for antigen detection were obtained from all patients presenting with respiratory symptoms; (2) all diagnosed (or suspected) PIV3-positive hematological patients were nursed following contact isolation precautions, preferably in the Infectious Diseases Unit; and (3) staff were given further education on hospital hygiene. Our experience shows that it may be possible to avoid mortality for PIV3 lower respiratory tract infection in immunocompromised patients by early commencement of intravenous ribavirin. It is also possible, even without closing the ward, to contain nosocomial spread of PIV3 by implementing systematic nasopharyngeal sampling for rapid diagnostics, and by strict adherence to cohorting and contact isolation precautions. Bone Marrow Transplantation (2001) 27, 295\u2013300.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/sj.bmt.1702776", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1096890", 
            "issn": [
              "0268-3369", 
              "1476-5365"
            ], 
            "name": "Bone Marrow Transplantation", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "27"
          }
        ], 
        "keywords": [
          "parainfluenza virus type 3", 
          "lower respiratory tract infections", 
          "respiratory tract infections", 
          "tract infections", 
          "isolation precautions", 
          "hematology unit", 
          "parainfluenza virus type 3 infection", 
          "intravenous ribavirin therapy", 
          "contact isolation precautions", 
          "Infectious Diseases Unit", 
          "type 3 infection", 
          "high mortality rate", 
          "virus type 3", 
          "PIV3 infection", 
          "intravenous ribavirin", 
          "ribavirin therapy", 
          "BMT recipients", 
          "respiratory symptoms", 
          "hematological patients", 
          "nasopharyngeal samples", 
          "nosocomial spread", 
          "nosocomial origin", 
          "Diseases Unit", 
          "chest radiographs", 
          "hematological malignancies", 
          "mortality rate", 
          "patients", 
          "early commencement", 
          "infection", 
          "antigen detection", 
          "hospital hygiene", 
          "type 3", 
          "strict adherence", 
          "rapid diagnostics", 
          "cohorting", 
          "infiltrate", 
          "ribavirin", 
          "nasopharyngeal", 
          "malignancy", 
          "therapy", 
          "symptoms", 
          "radiographs", 
          "mortality", 
          "disease", 
          "wards", 
          "recipients", 
          "precautions", 
          "adherence", 
          "further education", 
          "hygiene", 
          "spread", 
          "commencement", 
          "staff", 
          "units", 
          "period", 
          "rate", 
          "experience", 
          "diagnostics", 
          "samples", 
          "education", 
          "detection", 
          "origin", 
          "policy", 
          "spread of PIV3", 
          "PIV3-positive hematological patients", 
          "PIV3 lower respiratory tract infection", 
          "systematic nasopharyngeal", 
          "Bone Marrow Transplantation (2001) 27", 
          "Transplantation (2001) 27", 
          "virus type 3 infections"
        ], 
        "name": "Parainfluenza virus type 3 infections in a hematology unit", 
        "pagination": "295-300", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1026152219"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/sj.bmt.1702776"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "11277177"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/sj.bmt.1702776", 
          "https://app.dimensions.ai/details/publication/pub.1026152219"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:12", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_328.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/sj.bmt.1702776"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702776'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702776'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702776'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702776'


     

    This table displays all metadata directly associated to this object as RDF triples.

    271 TRIPLES      22 PREDICATES      120 URIs      107 LITERALS      25 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/sj.bmt.1702776 schema:about N0265ed878ffd473f9ea1577dbc30ef82
    2 N22066849466b40f793317704a28f2e89
    3 N22947b07663f4ccdb1d4cb04e56cc9b6
    4 N3936210261d74d5fba20dd37dd8b594f
    5 N429a72ae5b214694b3a63f5cd795b379
    6 N5ef525880db94d97bfc1535955f50fdb
    7 N67306c2831e34eabb0430c835a5b10a7
    8 N6c57a29b218240b19e04557417b1d21a
    9 N7f3e85d31e294a82a0d98c4a38fcaf81
    10 N822d05cfffba4490aa5a7ef77e20b2c6
    11 N8dc75cfd796048a8b9cdebce68fea3fc
    12 Na34e2b32cafc429082e9df99977012f5
    13 Nb32c8998af594d2eb43cc2de9295328e
    14 Nb7ccf9b8910d4bd0852f61908486918a
    15 Nd0becbb3d7644e2b899c4323c5a8a285
    16 Nd7d84e69b9084de28b8f553a7c29c8ba
    17 Neb09b868b9de45d986f0050e06839dc1
    18 Nec2859b49ceb4ed29f96db830da3f457
    19 anzsrc-for:11
    20 anzsrc-for:1103
    21 anzsrc-for:1108
    22 schema:author Ne28c0cb263684d41be7ff02da8cb54ef
    23 schema:citation sg:pub.10.1007/978-1-4612-3900-0_4
    24 sg:pub.10.1007/bf02009383
    25 sg:pub.10.1038/289187a0
    26 sg:pub.10.1038/sj.bmt.1700752
    27 schema:datePublished 2001-02
    28 schema:datePublishedReg 2001-02-01
    29 schema:description Parainfluenza virus type 3 (PIV3) is associated with a high mortality rate in BMT recipients with lower respiratory tract infections. We describe nine patients with hematological malignancies (five having undergone either allogeneic or autologous stem cell trans- plantation) identified as having PIV3 infection during a 2-month period in a Hematology Unit. Four patients with infiltrates on chest radiograph received intravenous ribavirin therapy; all survived. The infection was community-acquired in two patients, while nosocomial origin of the disease was evident, or presumed, in the remaining seven. The policy implemented to control the spread of PIV3 was as follows: (1) nasopharyngeal samples for antigen detection were obtained from all patients presenting with respiratory symptoms; (2) all diagnosed (or suspected) PIV3-positive hematological patients were nursed following contact isolation precautions, preferably in the Infectious Diseases Unit; and (3) staff were given further education on hospital hygiene. Our experience shows that it may be possible to avoid mortality for PIV3 lower respiratory tract infection in immunocompromised patients by early commencement of intravenous ribavirin. It is also possible, even without closing the ward, to contain nosocomial spread of PIV3 by implementing systematic nasopharyngeal sampling for rapid diagnostics, and by strict adherence to cohorting and contact isolation precautions. Bone Marrow Transplantation (2001) 27, 295–300.
    30 schema:genre article
    31 schema:inLanguage en
    32 schema:isAccessibleForFree true
    33 schema:isPartOf Nb1046ee740ac4e1b8e0b86acaea4e721
    34 Nf9542cf51605496aae1ee0f1e54fb897
    35 sg:journal.1096890
    36 schema:keywords BMT recipients
    37 Bone Marrow Transplantation (2001) 27
    38 Diseases Unit
    39 Infectious Diseases Unit
    40 PIV3 infection
    41 PIV3 lower respiratory tract infection
    42 PIV3-positive hematological patients
    43 Transplantation (2001) 27
    44 adherence
    45 antigen detection
    46 chest radiographs
    47 cohorting
    48 commencement
    49 contact isolation precautions
    50 detection
    51 diagnostics
    52 disease
    53 early commencement
    54 education
    55 experience
    56 further education
    57 hematological malignancies
    58 hematological patients
    59 hematology unit
    60 high mortality rate
    61 hospital hygiene
    62 hygiene
    63 infection
    64 infiltrate
    65 intravenous ribavirin
    66 intravenous ribavirin therapy
    67 isolation precautions
    68 lower respiratory tract infections
    69 malignancy
    70 mortality
    71 mortality rate
    72 nasopharyngeal
    73 nasopharyngeal samples
    74 nosocomial origin
    75 nosocomial spread
    76 origin
    77 parainfluenza virus type 3
    78 parainfluenza virus type 3 infection
    79 patients
    80 period
    81 policy
    82 precautions
    83 radiographs
    84 rapid diagnostics
    85 rate
    86 recipients
    87 respiratory symptoms
    88 respiratory tract infections
    89 ribavirin
    90 ribavirin therapy
    91 samples
    92 spread
    93 spread of PIV3
    94 staff
    95 strict adherence
    96 symptoms
    97 systematic nasopharyngeal
    98 therapy
    99 tract infections
    100 type 3
    101 type 3 infection
    102 units
    103 virus type 3
    104 virus type 3 infections
    105 wards
    106 schema:name Parainfluenza virus type 3 infections in a hematology unit
    107 schema:pagination 295-300
    108 schema:productId N1b516e1d5d7d44b5a11fe4748d6a4811
    109 N5c7e80851cfa494d839f44655e315ffa
    110 Ndd67284953fe4d689c5d06e732a69c74
    111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026152219
    112 https://doi.org/10.1038/sj.bmt.1702776
    113 schema:sdDatePublished 2021-12-01T19:12
    114 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    115 schema:sdPublisher N789bac2108cb46d8b98fd32d8ad0e863
    116 schema:url https://doi.org/10.1038/sj.bmt.1702776
    117 sgo:license sg:explorer/license/
    118 sgo:sdDataset articles
    119 rdf:type schema:ScholarlyArticle
    120 N0265ed878ffd473f9ea1577dbc30ef82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Female
    122 rdf:type schema:DefinedTerm
    123 N0bcbcd3b056846efb8133a46be827331 rdf:first sg:person.01342274627.34
    124 rdf:rest N69869ce2fb7140379bf58cb2d5162ec5
    125 N1b516e1d5d7d44b5a11fe4748d6a4811 schema:name dimensions_id
    126 schema:value pub.1026152219
    127 rdf:type schema:PropertyValue
    128 N22066849466b40f793317704a28f2e89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Hematology
    130 rdf:type schema:DefinedTerm
    131 N22947b07663f4ccdb1d4cb04e56cc9b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Parainfluenza Virus 3, Human
    133 rdf:type schema:DefinedTerm
    134 N3936210261d74d5fba20dd37dd8b594f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Cross Infection
    136 rdf:type schema:DefinedTerm
    137 N429a72ae5b214694b3a63f5cd795b379 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Middle Aged
    139 rdf:type schema:DefinedTerm
    140 N5c7e80851cfa494d839f44655e315ffa schema:name doi
    141 schema:value 10.1038/sj.bmt.1702776
    142 rdf:type schema:PropertyValue
    143 N5ef525880db94d97bfc1535955f50fdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Adult
    145 rdf:type schema:DefinedTerm
    146 N67306c2831e34eabb0430c835a5b10a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Humans
    148 rdf:type schema:DefinedTerm
    149 N69869ce2fb7140379bf58cb2d5162ec5 rdf:first sg:person.0742670020.35
    150 rdf:rest Nd92465edfe01494d86a8fbe77a116f38
    151 N6c57a29b218240b19e04557417b1d21a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Aged
    153 rdf:type schema:DefinedTerm
    154 N789bac2108cb46d8b98fd32d8ad0e863 schema:name Springer Nature - SN SciGraph project
    155 rdf:type schema:Organization
    156 N7f3e85d31e294a82a0d98c4a38fcaf81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Finland
    158 rdf:type schema:DefinedTerm
    159 N822d05cfffba4490aa5a7ef77e20b2c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Paramyxoviridae Infections
    161 rdf:type schema:DefinedTerm
    162 N8dc75cfd796048a8b9cdebce68fea3fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Hematopoietic Stem Cell Transplantation
    164 rdf:type schema:DefinedTerm
    165 Na34e2b32cafc429082e9df99977012f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Hospital Units
    167 rdf:type schema:DefinedTerm
    168 Na3b0c921e0cd4f08bdd492a870365265 rdf:first sg:person.0612620377.46
    169 rdf:rest N0bcbcd3b056846efb8133a46be827331
    170 Nb1046ee740ac4e1b8e0b86acaea4e721 schema:issueNumber 3
    171 rdf:type schema:PublicationIssue
    172 Nb32c8998af594d2eb43cc2de9295328e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Ribavirin
    174 rdf:type schema:DefinedTerm
    175 Nb7ccf9b8910d4bd0852f61908486918a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Hematologic Neoplasms
    177 rdf:type schema:DefinedTerm
    178 Nd0becbb3d7644e2b899c4323c5a8a285 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Male
    180 rdf:type schema:DefinedTerm
    181 Nd7d84e69b9084de28b8f553a7c29c8ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Immunocompromised Host
    183 rdf:type schema:DefinedTerm
    184 Nd92465edfe01494d86a8fbe77a116f38 rdf:first sg:person.01231423755.90
    185 rdf:rest Nf9b1a9a896ec402083973245f30a0762
    186 Ndd67284953fe4d689c5d06e732a69c74 schema:name pubmed_id
    187 schema:value 11277177
    188 rdf:type schema:PropertyValue
    189 Ne28c0cb263684d41be7ff02da8cb54ef rdf:first sg:person.01023540424.78
    190 rdf:rest Nf0031562ae744512ad7767cc4644e997
    191 Neb09b868b9de45d986f0050e06839dc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name Antigens, Viral
    193 rdf:type schema:DefinedTerm
    194 Nec2859b49ceb4ed29f96db830da3f457 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    195 schema:name Follow-Up Studies
    196 rdf:type schema:DefinedTerm
    197 Nf0031562ae744512ad7767cc4644e997 rdf:first sg:person.0623450752.49
    198 rdf:rest Na3b0c921e0cd4f08bdd492a870365265
    199 Nf9542cf51605496aae1ee0f1e54fb897 schema:volumeNumber 27
    200 rdf:type schema:PublicationVolume
    201 Nf9b1a9a896ec402083973245f30a0762 rdf:first sg:person.01137767024.86
    202 rdf:rest rdf:nil
    203 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    204 schema:name Medical and Health Sciences
    205 rdf:type schema:DefinedTerm
    206 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    207 schema:name Clinical Sciences
    208 rdf:type schema:DefinedTerm
    209 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
    210 schema:name Medical Microbiology
    211 rdf:type schema:DefinedTerm
    212 sg:journal.1096890 schema:issn 0268-3369
    213 1476-5365
    214 schema:name Bone Marrow Transplantation
    215 schema:publisher Springer Nature
    216 rdf:type schema:Periodical
    217 sg:person.01023540424.78 schema:affiliation grid-institutes:grid.410552.7
    218 schema:familyName Hohenthal
    219 schema:givenName U
    220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023540424.78
    221 rdf:type schema:Person
    222 sg:person.01137767024.86 schema:affiliation grid-institutes:grid.410552.7
    223 schema:familyName Kotilainen
    224 schema:givenName P
    225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137767024.86
    226 rdf:type schema:Person
    227 sg:person.01231423755.90 schema:affiliation grid-institutes:grid.410552.7
    228 schema:familyName Itälä
    229 schema:givenName M
    230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231423755.90
    231 rdf:type schema:Person
    232 sg:person.01342274627.34 schema:affiliation grid-institutes:grid.410552.7
    233 schema:familyName Peltonen
    234 schema:givenName R
    235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342274627.34
    236 rdf:type schema:Person
    237 sg:person.0612620377.46 schema:affiliation grid-institutes:grid.1374.1
    238 schema:familyName Vainionpää
    239 schema:givenName R
    240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0612620377.46
    241 rdf:type schema:Person
    242 sg:person.0623450752.49 schema:affiliation grid-institutes:grid.410552.7
    243 schema:familyName Nikoskelainen
    244 schema:givenName J
    245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623450752.49
    246 rdf:type schema:Person
    247 sg:person.0742670020.35 schema:affiliation grid-institutes:grid.410552.7
    248 schema:familyName Routamaa
    249 schema:givenName M
    250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742670020.35
    251 rdf:type schema:Person
    252 sg:pub.10.1007/978-1-4612-3900-0_4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016607238
    253 https://doi.org/10.1007/978-1-4612-3900-0_4
    254 rdf:type schema:CreativeWork
    255 sg:pub.10.1007/bf02009383 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013894701
    256 https://doi.org/10.1007/bf02009383
    257 rdf:type schema:CreativeWork
    258 sg:pub.10.1038/289187a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038585061
    259 https://doi.org/10.1038/289187a0
    260 rdf:type schema:CreativeWork
    261 sg:pub.10.1038/sj.bmt.1700752 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017083491
    262 https://doi.org/10.1038/sj.bmt.1700752
    263 rdf:type schema:CreativeWork
    264 grid-institutes:grid.1374.1 schema:alternateName Department of Virology, Turku University, Turku, Finland
    265 schema:name Department of Virology, Turku University, Turku, Finland
    266 rdf:type schema:Organization
    267 grid-institutes:grid.410552.7 schema:alternateName Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland
    268 Department of Surgery, Turku University Central Hospital, Turku, Finland
    269 schema:name Department of Medicine, Divisions of Hematology and Infectious Diseases, Turku University Central Hospital, Turku, Finland
    270 Department of Surgery, Turku University Central Hospital, Turku, Finland
    271 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...